1871 Folsom Street
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.
April 20, 2009
Founders: Patrick Mahaffy, and Erle Mast
CEO and Co-founder: Patrick Mahaffy
CMO (Medical): Lindsey Rolfe
Please click here for Clovis Oncology job opportunities.
Please click here for clinical trial information.